Skip to main content

BOSTON SCIENTIFIC CORP (BSX) Stock Forecast 2025 - AI Price Prediction & Analysis


BOSTON SCIENTIFIC CORP (BSX) AI Stock Price Forecast & Investment Analysis

BOSTON SCIENTIFIC CORP Stock Price Chart and Technical Analysis

Loading BOSTON SCIENTIFIC CORP interactive price chart and technical analysis...

BOSTON SCIENTIFIC CORP (BSX) - Comprehensive Stock Analysis & Investment Research

Deep dive into BOSTON SCIENTIFIC CORP's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about BOSTON SCIENTIFIC CORP, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For BOSTON SCIENTIFIC CORP: BOSTON SCIENTIFIC CORP operates in the Industrial Applications and Services sector, positioning it as a large-cap market leader.

BOSTON SCIENTIFIC CORP (Stock Symbol: BSX) is a leading company in the Industrial Applications and Services sector , specifically operating within the Surgical & Medical Instruments & Apparatus industry.

The organization employs approximately 45000 professionals worldwide .

The company has established itself as a major market leader with significant institutional backing.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing BOSTON SCIENTIFIC CORP's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For BOSTON SCIENTIFIC CORP: With $18494M in annual revenue and 8.6% net margin, the company demonstrates solid profitability.

Annual Revenue: $18494 million generating a 8.6% net profit margin .

Market Capitalization: $144402 million - Classified as a large-cap stock with institutional-grade stability.

Return on Equity (ROE): 4.7% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for BOSTON SCIENTIFIC CORP stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For BOSTON SCIENTIFIC CORP: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for BOSTON SCIENTIFIC CORP stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: BOSTON SCIENTIFIC CORP's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For BOSTON SCIENTIFIC CORP: Strong free cash flow generation demonstrates solid operational efficiency.

BOSTON SCIENTIFIC CORP strategically competes in the highly dynamic Surgical & Medical Instruments & Apparatus marketplace, positioning itself as a dominant large-cap market leader with significant competitive moats and institutional investor confidence .

The company demonstrates robust operational efficiency through strong free cash flow generation of $928 million annually, complemented by impressive -17.9% year-over-year cash flow growth.

The company maintains a healthy 498.6% gross margin, indicating strong pricing power and operational efficiency.

BOSTON SCIENTIFIC CORP (BSX) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for BOSTON SCIENTIFIC CORP stock analysis.

Loading BOSTON SCIENTIFIC CORP comprehensive fundamental analysis and insider trading data...

Deep dive into BOSTON SCIENTIFIC CORP's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if BOSTON SCIENTIFIC CORP stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For BOSTON SCIENTIFIC CORP: With a P/E ratio of 57.62, the market highly values future growth prospects.

P/E Ratio 57.62x
P/B Ratio 6.44x
Market Cap $144402M
Dividend Yield 0.45%
EPS $1.69
Book Value/Share $15.01
Revenue/Share $12.38
FCF/Share $0.80
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently BOSTON SCIENTIFIC CORP converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For BOSTON SCIENTIFIC CORP: An ROE of 4.7% indicates room for improvement in shareholder value creation.

ROE 4.7%
ROA 2.4%
ROIC 4.8%
Gross Margin 498.6%
Operating Margin 114.1%
Net Margin 8.6%
EBT Margin 7.5%
Tax Rate 10.7%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess BOSTON SCIENTIFIC CORP's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For BOSTON SCIENTIFIC CORP: A current ratio of 1.18 shows adequate liquidity.

Current Ratio 1.18x
Quick Ratio 0.51x
D/E Ratio 0.56x
Financial Leverage 1.93x
Interest Coverage 2.7x
Working Capital $3013M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal BOSTON SCIENTIFIC CORP's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For BOSTON SCIENTIFIC CORP: Free cash flow of $928M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $1528M
Free Cash Flow $928M
Capital Spending $-600M
OCF Growth YoY -17.9%
FCF Growth YoY -17.7%
FCF/Sales 7.6%
CapEx/Sales 4.9%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively BOSTON SCIENTIFIC CORP uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For BOSTON SCIENTIFIC CORP: An asset turnover of 0.38x suggests room for improvement in asset utilization.

Asset Turnover 0.38x
Receivables Turnover 7.0x
Inventory Turnover 2.4x
Fixed Assets Turnover 4.7x
Days Sales Outstanding 52 days
Days Inventory 150 days
Payables Period 63 days
Cash Conversion Cycle 140 days
Understanding Financial Statement Data

What these metrics mean: Key figures from BOSTON SCIENTIFIC CORP's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For BOSTON SCIENTIFIC CORP: With annual revenue of $18494M, BOSTON SCIENTIFIC CORP operates at significant scale.

Income Statement ($ Millions)
Total Revenue $18494M
R&D Expense $10M
SG&A Expense $36M
Cost of Goods Sold $4937M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 16%
Cash & Short-term Investments 1%
Total Liabilities 48%
Short-term Debt 1%
Accounts Receivable 6%
Inventory 5%
Dividend & Shareholder Information
Dividends Per Share $0.20
Payout Ratio 4.6%
Shares Outstanding 1493M
Growth Metrics (YoY)
EPS Growth 1.2%

Latest BOSTON SCIENTIFIC CORP Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting BOSTON SCIENTIFIC CORP (BSX) stock price and investment outlook.

BOSTON SCIENTIFIC CORP Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of BOSTON SCIENTIFIC CORP against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ADGM Unlock Forecast - 30 Days FREE Trial $26M x 3.0x
ALUR Unlock Forecast - 30 Days FREE Trial $17M -0.4x -0.3x
ANGO Unlock Forecast - 30 Days FREE Trial $442M -1.4x 2.4x
ANIK Unlock Forecast - 30 Days FREE Trial $128M -4.3x 0.9x
AORT Unlock Forecast - 30 Days FREE Trial $1805M -198.2x 4.3x
APYX Unlock Forecast - 30 Days FREE Trial $89M -3.5x 12.3x
ATEC Unlock Forecast - 30 Days FREE Trial $2274M -7.4x 95.7x
ATRC Unlock Forecast - 30 Days FREE Trial $1810M -39.6x 3.9x
AVHHL Unlock Forecast - 30 Days FREE Trial $27M x x
BAX Unlock Forecast - 30 Days FREE Trial $12132M -94.9x 1.7x
BBNX Unlock Forecast - 30 Days FREE Trial $976M x 3.2x
BDX Unlock Forecast - 30 Days FREE Trial $53749M 33.9x 2.1x
BEAT Unlock Forecast - 30 Days FREE Trial $57M -5.7x 13.8x
BJDX Unlock Forecast - 30 Days FREE Trial $2M -0.5x 0.4x
BSX Unlock Forecast - 30 Days FREE Trial $144402M 57.6x 6.4x
BVS Unlock Forecast - 30 Days FREE Trial $595M -18.3x 3.7x
CARL Unlock Forecast - 30 Days FREE Trial $-20M x x
CLPT Unlock Forecast - 30 Days FREE Trial $318M -23.5x 16.1x
CODX Unlock Forecast - 30 Days FREE Trial $16M -0.7x 0.4x
CVRX Unlock Forecast - 30 Days FREE Trial $187M -5.5x 3.2x
DCTH Unlock Forecast - 30 Days FREE Trial $460M 206.2x 4.4x
DRTS Unlock Forecast - 30 Days FREE Trial $348M x 4.0x
DXCM Unlock Forecast - 30 Days FREE Trial $30903M 54.1x 12.0x
EBRCZ Unlock Forecast - 30 Days FREE Trial $337M x 6.8x
FEMY Unlock Forecast - 30 Days FREE Trial $11M -1.4x 7.6x
FOFA Unlock Forecast - 30 Days FREE Trial $8M x 14.6x
GIPL Unlock Forecast - 30 Days FREE Trial $5M x 25.6x
GKOS Unlock Forecast - 30 Days FREE Trial $4914M -46.3x 6.4x
GMED Unlock Forecast - 30 Days FREE Trial $7839M 22.0x 1.8x
HRGN Unlock Forecast - 30 Days FREE Trial $31M x 40.6x
IART Unlock Forecast - 30 Days FREE Trial $1099M 200.2x 1.1x
ICCM Unlock Forecast - 30 Days FREE Trial $62M x 21.3x
ICUI Unlock Forecast - 30 Days FREE Trial $3248M -49.8x 1.6x
IDXG Unlock Forecast - 30 Days FREE Trial $23M 4.4x -0.9x
IINN Unlock Forecast - 30 Days FREE Trial $30M x 7.0x
IINNW Unlock Forecast - 30 Days FREE Trial $8M x 1.9x
INBS Unlock Forecast - 30 Days FREE Trial $9M -0.3x 3.0x
INFU Unlock Forecast - 30 Days FREE Trial $213M 42.0x 3.9x
INSP Unlock Forecast - 30 Days FREE Trial $2365M 44.5x 3.5x
IRMD Unlock Forecast - 30 Days FREE Trial $905M 43.8x 9.6x
IRTC Unlock Forecast - 30 Days FREE Trial $5663M -20.2x 54.6x
KIDS Unlock Forecast - 30 Days FREE Trial $448M -20.7x 1.3x
KMTS Unlock Forecast - 30 Days FREE Trial $1350M x x
KRMD Unlock Forecast - 30 Days FREE Trial $192M -19.8x 11.6x
LNSR Unlock Forecast - 30 Days FREE Trial $59M -6.7x -7.0x
LUCD Unlock Forecast - 30 Days FREE Trial $111M -0.6x 14.1x
LUNG Unlock Forecast - 30 Days FREE Trial $69M -4.3x 1.0x
MCAG Unlock Forecast - 30 Days FREE Trial $22M x -9.6x
MCAGU Unlock Forecast - 30 Days FREE Trial $21M x -9.9x
MDNC Unlock Forecast - 30 Days FREE Trial $59M 26.8x 13.4x
MDXG Unlock Forecast - 30 Days FREE Trial $1050M 32.6x 4.9x
MGRM Unlock Forecast - 30 Days FREE Trial $211M -10.7x 24.5x
MHUA Unlock Forecast - 30 Days FREE Trial $13M x 0.1x
MMM Unlock Forecast - 30 Days FREE Trial $85312M 21.7x 19.9x
MMSI Unlock Forecast - 30 Days FREE Trial $5093M 42.8x 3.4x
NEPH Unlock Forecast - 30 Days FREE Trial $39M -20.3x 2.0x
NMTC Unlock Forecast - 30 Days FREE Trial $46M -1.7x 5.7x
NPCE Unlock Forecast - 30 Days FREE Trial $328M -10.4x 16.9x
NSPR Unlock Forecast - 30 Days FREE Trial $124M -4.3x 6.1x
NVCR Unlock Forecast - 30 Days FREE Trial $1419M -20.8x 4.1x
NXGL Unlock Forecast - 30 Days FREE Trial $22M -6.8x 4.6x
OBIO Unlock Forecast - 30 Days FREE Trial $118M -3.4x 2.0x
OFIX Unlock Forecast - 30 Days FREE Trial $581M -5.8x 1.3x
OSRH Unlock Forecast - 30 Days FREE Trial $25M x 0.3x
OSUR Unlock Forecast - 30 Days FREE Trial $253M 17.1x 0.7x
PAVM Unlock Forecast - 30 Days FREE Trial $20M 0.3x 0.5x
PDEX Unlock Forecast - 30 Days FREE Trial $115M 12.9x 3.2x
PEN Unlock Forecast - 30 Days FREE Trial $10023M 67.9x 7.8x
PLRZ Unlock Forecast - 30 Days FREE Trial $7M x 0.4x
PMI Unlock Forecast - 30 Days FREE Trial $44M x x
PODD Unlock Forecast - 30 Days FREE Trial $23559M 99.8x 16.1x
PRCT Unlock Forecast - 30 Days FREE Trial $2075M -45.4x 5.4x
PROF Unlock Forecast - 30 Days FREE Trial $130M x 3.3x
PYPD Unlock Forecast - 30 Days FREE Trial $54M x 2.6x
RCEL Unlock Forecast - 30 Days FREE Trial $145M -5.0x -29.9x
RDGL Unlock Forecast - 30 Days FREE Trial $42M x 15.8x
RMD Unlock Forecast - 30 Days FREE Trial $40361M 28.8x 6.8x
RSMDF Unlock Forecast - 30 Days FREE Trial $3663M 2.6x 0.6x
RTGN Unlock Forecast - 30 Days FREE Trial $66M x x
RVP Unlock Forecast - 30 Days FREE Trial $25M -0.9x 0.3x
SGHT Unlock Forecast - 30 Days FREE Trial $187M -3.7x 2.7x
SIBN Unlock Forecast - 30 Days FREE Trial $628M -14.3x 3.7x
SKIN Unlock Forecast - 30 Days FREE Trial $321M -1.8x 4.3x
SNOA Unlock Forecast - 30 Days FREE Trial $7M -5.6x 1.7x
SNWV Unlock Forecast - 30 Days FREE Trial $299M x -19.4x
SOLV Unlock Forecast - 30 Days FREE Trial $13015M 34.3x 3.6x
SRTS Unlock Forecast - 30 Days FREE Trial $51M 31.6x 1.0x
SSKN Unlock Forecast - 30 Days FREE Trial $7M -8.0x 21.3x
STIM Unlock Forecast - 30 Days FREE Trial $213M -1.0x 7.9x
STME Unlock Forecast - 30 Days FREE Trial $12M x x
STSS Unlock Forecast - 30 Days FREE Trial $8M -2.5x 0.6x
SYK Unlock Forecast - 30 Days FREE Trial $140684M 42.0x 12.0x
TCMD Unlock Forecast - 30 Days FREE Trial $333M 22.0x 1.7x
TELA Unlock Forecast - 30 Days FREE Trial $73M -1.8x 8.0x
TFX Unlock Forecast - 30 Days FREE Trial $5676M 29.6x 1.3x
TNDM Unlock Forecast - 30 Days FREE Trial $849M -17.1x 6.4x
TNON Unlock Forecast - 30 Days FREE Trial $10M -0.3x 1.4x
USAQ Unlock Forecast - 30 Days FREE Trial $2M x x
UTMD Unlock Forecast - 30 Days FREE Trial $204M 16.2x 1.7x
VERO Unlock Forecast - 30 Days FREE Trial $5M 0.0x 2.2x
WST Unlock Forecast - 30 Days FREE Trial $18563M 38.1x 6.3x
XTNT Unlock Forecast - 30 Days FREE Trial $96M -478.8x 2.0x

Frequently Asked Questions - BOSTON SCIENTIFIC CORP Stock Forecast

How accurate are BOSTON SCIENTIFIC CORP stock predictions?

Our AI model demonstrates -1% historical accuracy for BSX predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence BOSTON SCIENTIFIC CORP stock price forecasts?

Our analysis considers BOSTON SCIENTIFIC CORP's financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is BOSTON SCIENTIFIC CORP a good investment in 2025?

Based on our AI analysis, BOSTON SCIENTIFIC CORP shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are BOSTON SCIENTIFIC CORP forecasts updated?

BOSTON SCIENTIFIC CORP stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced BOSTON SCIENTIFIC CORP Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for BOSTON SCIENTIFIC CORP stock.

My Portfolio

Investment Dashboard

Loading your portfolio...